Participate in Research

Browse Clinical Trials
Clinical Trial for People with Diabetic Macular Edema
Protocol: STUDY00006860
Full Title
A MULTI-CENTER, NON-RANDOMIZED, OPEN-LABEL, MULTIPLE ASCENDING DOSE STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF RO7497372 FOLLOWING INTRAVITREAL ADMINISTRATION IN PARTICIPANTS WITH DIABETIC MACULAR EDEMA
Description
The University at Buffalo (UB) Department of Ophthalmology is looking for adult with diabetic macular edema (DME) for a clinical trial. DME results from diabetes damaging the blood vessels in your eye and can lead to blindness. The goal of the study is to see the effects (either good or bad) of a new drug (called RO7497372) to treat DME.

Participation in the study will last about 7 months and involve two parts. The first part will include injections of the study drug into one eye every 4 weeks. After 8 weeks, there will be a 4.5-month follow-up period when the study doctor will test to see if your DME has improved and for surveys, physical exams, and eye exams. Participants can earn $100 for each study visit and for aqueous humor (or fluid from the eye) sample totaling a maximum of $2300.00.
Compensation: Yes
?
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Eligibility
Adults over the age of 18 years old Have been diagnosed with diabetic macular edema
Age Group: Adults
Principal Investigator: Brian Madow
Contact(s)
SHARON MICHALOVIC
sab1@buffalo.edu
+1 716-881-7975

Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions
Study Team Login